Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Use of Entresto (Sacubitril/Valsartan) for the Treatment of Peripheral Arterial Disease

NCT02636283 is registered in ClinicalTrials.gov with University of Minnesota as lead sponsor.

NCT NCT02636283
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02636283 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Use of Entresto (Sacubitril/Valsartan) for the Treatment of Peripheral Arterial Disease
Lead sponsor
University of Minnesota
Phase
Phase 2
Overall status
Terminated
Start date
December 31, 2017
Completion date
November 1, 2018
Enrollment
6 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

peripheral arterial disease